DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,836,791 | -31.5% | 1,058,497 | -2.0% | 0.00% | -33.3% |
| Q2 2023 | $31,866,576 | -36.8% | 1,079,857 | -50.6% | 0.00% | +50.0% |
| Q1 2023 | $50,391,422 | -18.2% | 2,187,128 | -1.2% | 0.00% | -66.7% |
| Q4 2022 | $61,565,608 | -18.2% | 2,213,794 | -9.7% | 0.01% | -25.0% |
| Q3 2022 | $75,266,000 | -10.9% | 2,452,456 | -14.5% | 0.01% | 0.0% |
| Q2 2022 | $84,456,000 | -10.8% | 2,869,740 | -2.5% | 0.01% | 0.0% |
| Q1 2022 | $94,711,000 | -28.1% | 2,944,055 | -0.3% | 0.01% | -20.0% |
| Q4 2021 | $131,650,000 | -2.5% | 2,951,791 | +10.3% | 0.01% | -9.1% |
| Q3 2021 | $134,991,000 | -35.5% | 2,675,749 | +0.2% | 0.01% | -31.2% |
| Q2 2021 | $209,362,000 | +36.4% | 2,669,083 | -0.7% | 0.02% | +23.1% |
| Q1 2021 | $153,467,000 | -47.9% | 2,687,700 | -23.5% | 0.01% | -50.0% |
| Q4 2020 | $294,350,000 | +68.6% | 3,514,209 | -27.9% | 0.03% | +44.4% |
| Q3 2020 | $174,545,000 | +49.9% | 4,871,468 | +1.2% | 0.02% | +38.5% |
| Q2 2020 | $116,405,000 | +27.2% | 4,814,115 | -7.9% | 0.01% | 0.0% |
| Q1 2020 | $91,501,000 | +27.5% | 5,225,670 | +26.9% | 0.01% | +62.5% |
| Q4 2019 | $71,746,000 | -4.6% | 4,118,634 | -16.1% | 0.01% | -11.1% |
| Q3 2019 | $75,221,000 | -28.2% | 4,909,997 | -2.7% | 0.01% | -25.0% |
| Q2 2019 | $104,788,000 | -17.8% | 5,047,621 | -8.1% | 0.01% | -20.0% |
| Q1 2019 | $127,503,000 | +10.8% | 5,491,110 | -1.4% | 0.02% | -6.2% |
| Q4 2018 | $115,084,000 | -31.3% | 5,570,339 | -27.8% | 0.02% | -15.8% |
| Q3 2018 | $167,638,000 | +36.8% | 7,711,049 | -4.1% | 0.02% | +35.7% |
| Q2 2018 | $122,565,000 | -34.7% | 8,037,026 | -15.7% | 0.01% | -36.4% |
| Q1 2018 | $187,752,000 | +28.5% | 9,535,421 | +2.0% | 0.02% | +29.4% |
| Q4 2017 | $146,148,000 | – | 9,344,456 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,705,039 | $343,645,000 | 25.68% |
| Casdin Capital, LLC | 1,500,000 | $66,900,000 | 1.89% |
| Flagship Pioneering Inc. | 2,619,968 | $116,851,000 | 1.81% |
| SECTORAL ASSET MANAGEMENT INC | 189,600 | $8,456,000 | 1.27% |
| Integral Health Asset Management, LLC | 100,000 | $4,460,000 | 1.23% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $239,479,000 | 0.86% |
| Goldstream Capital Management Ltd | 78,418 | $3,497,000 | 0.86% |
| Yiheng Capital Management, L.P. | 335,184 | $14,949,000 | 0.76% |
| GILDER GAGNON HOWE & CO LLC | 2,900,114 | $129,345,000 | 0.74% |
| Artal Group S.A. | 600,000 | $26,760,000 | 0.73% |